ConductScience.org, home

Paper28463501

Hyaluronan Nanoparticles Selectively Target Plaque-Associated Macrophages and Improve Plaque Stability in Atherosclerosis.

Beldman TJ and 21 others. ACS Nano, 2017. Cited by 141 papers, by iCite.

Cite this record

ConductScience Library. Hyaluronan Nanoparticles Selectively Target Plaque-Associated Macrophages and Improve Plaque Stability in Atherosclerosis. Papers, record 28463501. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/28463501

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Hyaluronan Nanoparticles Selectively Target Plaque-Associated Macrophages and Improve Plaque Stability in Atherosclerosis.
PubMed
Journal
ACS Nano
PubMed
Year
2017
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
141
iCite
Relative citation ratio, by iCite
5.08
iCite
Revised in PubMed
2019-02-15
PubMed

Authors22

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Beldman TJThijs J
2Senders MLMax L
3Alaarg AAmr
4Pérez-Medina CCarlos
5Tang JJunhttps://orcid.org/0000-0002-8285-5111
6Zhao YYiming
7Fay FFrancoishttps://orcid.org/0000-0001-7405-5600
8Deichmöller JJacqueline
9Born BBenjamin
10Desclos EEmilie
11van der Wel NNNicole N
12Hoebe RARon A
13Kohen FFortune
14Kartvelishvily EElena
15Neeman MMichal
16Reiner TThomas
17Calcagno CClaudia
18Fayad ZAZahi A
19de Winther MPJMenno P J
20Lutgens EEsther

Source PubMed

See all 22 authorsDownload CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Anti-Inflammatory AgentsMajor topic
AtherosclerosisMajor topic
Hyaluronic AcidMajor topic
MacrophagesMajor topic
NanoparticlesMajor topic
Plaque, AtheroscleroticMajor topic
Animals
Male
Mice
Positron-Emission Tomography
Rabbits
Tissue Distribution

Source PubMed

Download CSV of topics

Grants5

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
R01 HL125703NHLBI NIH HHSUnited StatesR01HL125703PubMed and NIHNIH RePORTER
P01 HL131478NHLBI NIH HHSUnited StatesP01HL131478PubMed and NIHNIH RePORTER
P30 CA008748NCI NIH HHSUnited StatesP30CA008748PubMed and NIHNIH RePORTER
R01 EB009638NIBIB NIH HHSUnited StatesR01EB009638PubMed and NIHNIH RePORTER
R01 HL118440NHLBI NIH HHSUnited StatesR01HL118440PubMed and NIHNIH RePORTER

Download CSV of grants

References79

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
115229478Hyaluronan: from extracellular glue to pericellular cue.Nat Rev Cancer2004https://conductscience.org/library/papers/15229478PubMed
220008845Hyaluronan-CD44 Interactions in Cancer: Paradoxes and Possibilities.Clin Cancer Res2009https://conductscience.org/library/papers/20008845PubMed
312194965Angiogenic oligosaccharides of hyaluronan induce multiple signaling pathways affecting vascular endothelial cell mitogenic and wound healing responses.J Biol Chem2002https://conductscience.org/library/papers/12194965PubMed
422592627Dual role of lipoproteins in endothelial cell dysfunction in atherosclerosis.Cell Tissue Res2012https://conductscience.org/library/papers/22592627PubMed
515705963Overexpression of hyaluronan in the tunica media promotes the development of atherosclerosis.Circ Res2005https://conductscience.org/library/papers/15705963PubMed
611853916Targeting to macrophages: role of physicochemical properties of particulate carriers--liposomes and microspheres--on the phagocytosis by macrophages.J Control Release2002https://conductscience.org/library/papers/11853916PubMed
721394792Hyaluronic acid hydrogels for biomedical applications.Adv Mater2011https://conductscience.org/library/papers/21394792PubMed
818758474Nanoparticle therapeutics: an emerging treatment modality for cancer.Nat Rev Drug Discov2008https://conductscience.org/library/papers/18758474PubMed
921967065Smart nanocarrier based on PEGylated hyaluronic acid for cancer therapy.ACS Nano2011https://conductscience.org/library/papers/21967065PubMed
1025619964Atherosclerotic plaque targeting mechanism of long-circulating nanoparticles established by multimodal imaging.ACS Nano2015https://conductscience.org/library/papers/25619964PubMed
1126295063Inhibiting macrophage proliferation suppresses atherosclerotic plaque inflammation.Sci Adv2015https://conductscience.org/library/papers/26295063PubMed
1224653726Hyaluronan, a crucial regulator of inflammation.Front Immunol2014https://conductscience.org/library/papers/24653726PubMed
132180732Binding of hyaluronic acid to lymphoid cell lines is inhibited by monoclonal antibodies against Pgp-1.Exp Cell Res1990https://conductscience.org/library/papers/2180732PubMed
1411717318Hyaluronan-cell interactions in cancer and vascular disease.J Biol Chem2002https://conductscience.org/library/papers/11717318PubMed
15762499Hyaluronidase-sensitive halos around adherent cells. Their role in blocking lymphocyte-mediated cytolysis.J Exp Med1979https://conductscience.org/library/papers/762499PubMed
1622693353Metronomic activity of CD44-targeted hyaluronic acid-paclitaxel in ovarian carcinoma.Clin Cancer Res2012https://conductscience.org/library/papers/22693353PubMed
1720202637FDG-PET imaging of atherosclerosis: Do we know what we see?Atherosclerosis2010https://conductscience.org/library/papers/20202637PubMed
1824445279A statin-loaded reconstituted high-density lipoprotein nanoparticle inhibits atherosclerotic plaque inflammation.Nat Commun2014https://conductscience.org/library/papers/24445279PubMed
1920977242Hyaluronic acid immobilized magnetic nanoparticles for active targeting and imaging of macrophages.Bioconjug Chem2010https://conductscience.org/library/papers/20977242PubMed
2017617562Cutting edge: high molecular weight hyaluronan promotes the suppressive effects of CD4+CD25+ regulatory T cells.J Immunol2007https://conductscience.org/library/papers/17617562PubMed

See all 79 referencesDownload CSV of references

Cited by80

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 141 citations.

PMIDTitleJournalYearIn PapersSource
42909384Atherosclerosis nanotheranostics: a perspective from macrophages.Theranostics2026https://conductscience.org/library/papers/42909384PubMed
42254054Polymeric Nanomaterials for Atherosclerosis Diagnosis and Treatment.Polym Sci Technol2025https://conductscience.org/library/papers/42254054PubMed
42108479Nootkatone confers MAOB-dependent neuroprotection against ferroptotic injury via brain-targeted nanoparticle delivery in ischemic stroke.J Nanobiotechnology2026https://conductscience.org/library/papers/42108479PubMed
42094740How Advanced is Nanomedicine to Treat Atherosclerosis? A Comprehensive Review of the Literature.Int J Nanomedicine2026https://conductscience.org/library/papers/42094740PubMed
41783546Nanozyme-Based Anti-Inflammatory Strategies in Cardiovascular Disease Management: Clinical Prospects and Challenges.Int J Nanomedicine2026https://conductscience.org/library/papers/41783546PubMed
41702598Macrophages in human atherosclerotic plaques in the era of single-cell and spatial transcriptomics.Immunohorizons2026https://conductscience.org/library/papers/41702598PubMed
41012478A New Approach to the Diagnosis and Treatment of Cardiovascular Diseases.Pharmaceutics2025https://conductscience.org/library/papers/41012478PubMed
40717066Nanomedicine in cardiovascular and cerebrovascular diseases: targeted nanozyme therapies and their clinical potential and current challenges.J Nanobiotechnology2025https://conductscience.org/library/papers/40717066PubMed
40110293Essential information about nanotechnology in cardiology.Ann Med Surg (Lond)2025https://conductscience.org/library/papers/40110293PubMed
39917718Nanosystems for modulation of immune responses in periodontal therapy: a mini-review.Front Dent Med2024https://conductscience.org/library/papers/39917718PubMed
39752488Deciphering neutrophil dynamics: Enhanced phagocytosis of elastic particles and impact on vascular-targeted carrier performance.Sci Adv2025https://conductscience.org/library/papers/39752488PubMed
39743560Extracellular matrix in vascular homeostasis and disease.Nat Rev Cardiol2025https://conductscience.org/library/papers/39743560PubMed
39513306Stimuli-responsive Nano/Biomaterials for Smart Drug Delivery in Cardiovascular Diseases: Promises, Challenges and Outlooks.Curr Med Chem2025https://conductscience.org/library/papers/39513306PubMed
39239513Molecular imaging nanoprobes and their applications in atherosclerosis diagnosis.Theranostics2024https://conductscience.org/library/papers/39239513PubMed
39185808Dual-Function Nanoscale Coordination Polymer Nanoparticles for Targeted Diagnosis and Therapeutic Delivery in Atherosclerosis.Small2024https://conductscience.org/library/papers/39185808PubMed
38943654Hyaluronic Acid Nanoparticles with Parameters Required for In Vivo Applications: From Synthesis to Parametrization.Biomacromolecules2024https://conductscience.org/library/papers/38943654PubMed
38930939Nanoparticles as Drug Delivery Systems for the Targeted Treatment of Atherosclerosis.Molecules2024https://conductscience.org/library/papers/38930939PubMed
38794614Organic Nanoparticles in Progressing Cardiovascular Disease Treatment and Diagnosis.Polymers (Basel)2024https://conductscience.org/library/papers/38794614PubMed
38696700Targeting macrophages with multifunctional nanoparticles to detect and prevent atherosclerotic cardiovascular disease.Cardiovasc Res2024https://conductscience.org/library/papers/38696700PubMed
38672722Endovascular Drug Delivery.Life (Basel)2024https://conductscience.org/library/papers/38672722PubMed

See all 80 cited byDownload CSV of cited by

Genes5

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CD44960PubTator's text mininghttps://conductscience.org/library/genes/960NCBI Gene
HMMR3161PubTator's text mininghttps://conductscience.org/library/genes/3161NCBI Gene
ICAM13383PubTator's text mininghttps://conductscience.org/library/genes/3383NCBI Gene
LYVE110894PubTator's text mininghttps://conductscience.org/library/genes/10894NCBI Gene
TLR47099PubTator's text mininghttps://conductscience.org/library/genes/7099NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/28463501

GET https://conductscience.org/api/papers/v1/28463501/authors?page=2